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Aims To examine the prevalence of sustained ventricular tachycardia (VT) and sudden death (SD) in adults with atrial
repair of transposition of the great arteries (TGA) and to determine associated risk factors.
Methods
and results
In a single-centre review, we studied the outcome of 149 adults (mean age 28+ 7 years) who had undergone a
Mustard operation for TGA. During a mean follow-up of 9+ 6 years, sustained VT and/or SD occurred in 9%
(13/149) of the cohort. Sustained VT/SD was more likely to occur in patients with associated anatomic lesions
[hazard ratio (HR) 4.9, 95% CI 1.5–16.0], with NYHA class III (HR 9.8, 95% CI 3.0–31.6) and with an impaired
subaortic right ventricular (RV) ejection fraction (EF) (HR 2.2, 95% CI 1.2–4.0 per 10% decrease in EF). There
was an inverse correlation between the RV-EF and both age and QRS duration. Patients with a QRS duration
140 ms were at highest risk of sustained VT/SD (HR 13.6, 95% CI 2.9–63.4). Atrial tachyarrhythmia was detected
in 66 (44%) patients, but was not a statistically significant predictor of sustained VT/SD in our adult population (HR
2.7, 95% CI 0.6–13.0).
Conclusion Sustained VT/SD in adults after a Mustard operation for TGA are more common than previously described. Age,
systemic ventricular function, and QRS duration are interrelated and are associated with VT/SD. A QRS duration
140 ms helps to identify the high risk patient.
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Introduction
Complete transposition of the great arteries (TGA) is one of the
most common cyanotic heart defects in newborns and is found
in 2–3 of 10 000 live births.1,2 In the current era, adult patients
typically have undergone atrial switch operations, either a
Senning or a Mustard procedure.3,4 These operations confer phys-
iological repair, but the morphological right ventricle (RV) and its
tricuspid valve continue to support the systemic circulation. This
results in late complications including systemic ventricular failure,
systemic atrioventricular valve regurgitation, and rhythm
disturbances.5,6
In children and adolescents with TGA and atrial switch oper-
ations, supraventricular arrhythmias are well described and are
shown to be associated with sudden death (SD).7,8 However, as
this population ages, there is further deterioration in systemic ven-
tricular function and ventricular tachycardia (VT) can develop.9
We speculated that there may be a different risk profile for
adults with VT and/or SD events when compared with children.
Therefore, we sought to examine the prevalence of sustained
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VT/SD in adult patients with TGA after an atrial switch operation
and to determine risk factors associated with these events.
Methods
After approval from the institutional research ethics board, 149 adults
with complete TGA and a Mustard operation performed at the
regional paediatric referral hospital (Hospital for Sick Children,
Toronto, Canada) and who had regular follow-up at our centre
(Toronto Congenital Cardiac Center for Adults, Toronto, Canada)
were included. At our centre, only adult patients (age 16–18
years) are followed in our clinic.
The study cohort is a subset of a larger cohort of 564 paediatric
patients who had undergone an atrial switch operation at the local
referring paediatric hospital. Of the 564 operations performed, 512
patients survived to hospital discharge. There were an additional 129
known deaths during paediatric follow-up and 29 children (age ,18
years) who had ongoing follow-up at the paediatric hospital at the
time of data collection. Therefore, at the time of discharge from pae-
diatric care, there were 354 adult patients with atrial switch operations
alive, some of whom did not live locally, others who had moved and
others who were lost to follow-up. Of the remaining patients, 149
were followed regularly at our centre and were included in this study.
Routine care for these patients includes an annual clinical evaluation
with an electrocardiogram (ECG) and transthoracic echocardiography.
In the current era, cardiac magnetic resonance (CMR) imaging or
radionuclide angiography (in patients with pacemakers) is performed
every 2–4 years. A 24 h Holter ECG was performed at the discretion
of the treating cardiologist. Typical indications for performing a Holter
included marked bradycardia, symptomatic bradycardia, palpitation,
and presyncope/syncope. In some instance, they were performed as
part of routine surveillance.
The patients’ medical records were reviewed to collect demo-
graphic information, medical and surgical details including age at the
time of the atrial switch operation or pacemaker implantation,
current clinical status, ECG findings, Holter recordings, and results
from imaging studies. Patients were classified as simple transposition
if they had concordant atrioventricular and discordant ventriculoarter-
ial connections with an intact ventricular septum or only a small, hae-
modynamically not important ventricular septal defect. Simple
transposition also included patients with isolated patent ductus arter-
iosus or aortic coarctation. Complex transposition was defined by the
presence of an associated ventricular septal defect requiring closure at
the time of the Mustard procedure or other lesions, such as a ventri-
cular outflow tract obstruction. We studied the occurrence of events
(arrhythmias, death) after the transition of care from the paediatric to
the adult congenital clinic based on the clinical records and the findings
at the time of the last clinical visit.
The majority of patients had their last echocardiogram done at the
time of their last follow-up. Right ventricular systolic function was
assessed echocardiographically in all patients. Right ventricular systolic
function was graded by visual assessment as normal [RV-ejection
fraction (EF) 50%], mildly (RV-EF 40–49%), moderately (RV-EF
30–39%), or severely hypokinetic (RV-EF ,30%). We previously
demonstrated a statistically significant correlation between visually
assessed RV function on echocardiography and RV-EF derived from
CMR in our laboratory.10 Tricuspid regurgitation was assessed echo-
cardiographically and graded qualitatively by an experienced reader
as mild (Grade 1), moderate (Grade 2), moderately severe (Grade
3), or severe (Grade 4). Right ventricular function was quantitatively
assessed using CMR or radionuclide imaging in a subset (n ¼ 111) of
patients. The CMR and radionuclide methods used at our centre to
assess the systemic RV have been previously described and a good cor-
relation has been shown for ventricular EF by these two techniques
with 95% limits of agreement within 16%.10,11 QRS duration was
measured in the widest complex on the ECG.
Outcomes
Arrhythmias were classified as atrial tachycardia or VT based on docu-
mentation from a 12-lead ECG or Holter monitor recording. Atrial
tachycardia included atrial fibrillation, typical isthmus-dependent
atrial flutter and other intra-atrial tachycardias. Atrial tachycardia was
further divided into paroxysmal or persistent arrhythmias. Ventricular
tachycardia was classified as non-sustained (three or more consecutive
beats of ventricular origin, heart rate .100 b.p.m., lasting ,30 s) or
sustained (lasting .30 s). Sudden death was defined as an unexpected
death due to cardiovascular collapse within 1 h of the initial symptoms.
Cause of death was determined from hospital record review. An
adverse arrhythmic event was defined as an episode of sustained VT
or SD. Earlier outcomes for some of the patients in this series have
been previously reported.5,7,9,12
Statistical analysis
Data were analysed using STATA 8.2 statistical software (Stata Cor-
poration, College Station, TX, USA). Data are expressed as mean+
SD for normally distributed variables and as median with inter-quartile
range (IQR) for non-normal data. The IQR indicates the lower and
upper quartile of ordered observations and is essentially the range
of the middle 50% of the data. It is a measure of variation of non-
normally distributed data. Between-group comparisons were per-
formed using a Student’s t-test or a Mann–Whitney test for normally
and non-normally distributed data, respectively. Between-group com-
parison of categorical data was performed using the Pearson x2 test
or the Fisher’s exact test as appropriate. Comparison of normally dis-
tributed data over multiple patient groups was done by an
analysis-of-variance model followed by a Bonferroni correction. To
depict the relationship between age, QRS duration, and systemic RV
systolic function, patients were categorized into age-related quartiles.
However, in the univariate analysis, age is presented as a continuous
variable. Survival of patients was analysed using Kaplan–Meier
curves. Survival curves were for calculated for the duration of
follow-up at our centre (age at the last visit or age at death minus
age at the first clinic visit). Follow-up time was defined as time in
years after first presentation to the adult congenital cardiac clinic.
Hazard ratios for univariate predictors of outcome were calculated
with a Cox proportional hazard model for the duration of follow-up.
Owing to the small number (,20) of outcome events (sustained VT
and/or SD), no multivariate analysis was performed. Receiver operating
characteristic (ROC) curve analysis was used to determine the optimal
QRS duration to differentiate between patients with and without VT
and/or SD. A P-value ,0.05 was considered statistically significant.
Results
Patient characteristics
We identified 149 adult patients with regular clinical follow-up.
Demographic and clinical data are shown in Table 1. Echocardio-
graphic assessment was available for all patients and most patients
had the study performed at the time of their last clinic visit (IQR
0–8 months). Quantitative assessment of systemic ventricular
was available in 111 patients. Right ventricular-EF was calculated
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by magnetic resonance imaging in 81 patients (median time interval
to the last follow-up or death was 9 months, IQR 0–24 months)
and by radionuclide angiography in 30 patients (median time inter-
val to last follow-up or death 19 months, IQR 10–34 months).
In four non-survivors, no quantitative assessment of subaortic RV
function was available.
Arrhythmias
Sustained VT was documented in seven (5%) patients. All episodes
of sustained VT were documented on a 12-lead-ECG or on
intraoperative ECG monitors. Sustained VT was more frequently
documented in patients who were older (32+6 vs. 28+7
years, P ¼ 0.04) and who had lower functional class (NYHA class
III, 71 vs. 6%, P,0.001). Patients with sustained VT had lower sub-
aortic RV-EF (20+7 vs. 42+10%, P,0.001) and broader QRS
complexes (170+27 vs. 110+25 ms, P,0.001) compared with
patients without sustained VT. In all but one patient with sustained
VT, systemic RV-EF was ,30%. Fifty-seven percent (four of seven)
of the patients with sustained VT had complex TGA compared
with 27% (38/142) of patients without sustained VT (P¼ 0.09).
Sixty-two (42%) patients had episodes of paroxysmal atrial
tachyarrhythmias and four (3%) patients were in persistent atrial
fibrillation. Patients with atrial tachyarrhythmia were older (30+
7 vs. 26+ 6 years, P,0.001), had lower RV-EF (39+ 12 vs.
43+11%, P ¼ 0.052), and had more significant tricuspid regurgita-
tion (more than moderate tricuspid regurgitation in 41 vs. 18%,
P ¼ 0.002) compared with patients without atrial tachyarrhyth-
mias. Six of the 62 patients with atrial tachyarrhythmias also had
sustained VT during follow-up.
In 35 patients, a pacemaker had been implanted at a mean age of
19+10 years. Pacemakers were implanted for sick sinus syn-
drome in 23 patients, complete heart block in six patients and to
permit medical therapy of atrial arrhythmias in six patients. Eight
patients exhibited permanent ventricular pacing on the last avail-
able 12-lead-ECG. Ten patients had implantable cardioverter defi-
brillator (ICD) placement at a mean age of 30+ 6 years. In seven
patients, the ICD implantation was performed after an episode of
VT. Three other ICDs were implanted prophylactically in patients
with bradyarrhythmias (two with sick sinus syndrome and one with
complete heart block) and severe systemic RV dysfunction.
Survival
In our clinical cohort, there were 13 deaths at a mean age 26+7
years. The mean period of follow-up in our clinic was 9+6 years.
Table 2 lists the clinical details pertaining to the cause of death. Of
these, 11 were classified as cardiac-related deaths, including eight
SD or deaths due to intractable VT. Two deaths were due to
neurological events. After 10 and 20 years of follow-up and after
transition of care to the adult clinic, 93% (95% CI 86–96%) and
73% (95% CI 48–87%) of patients were alive, respectively.
Right ventricular function
By quantitative measurement of resting systemic ventricular func-
tion, the oldest quartile of patients (age .32 years) had a signifi-
cantly lower RV-EF compared with patients ,28 years of age
(Table 3). In the oldest quartile of patients with quantitative
measurements of RV-EF, only two of thirty-three (6%) patients
had normal RV-EF (50%). There was an association between
depressed RV systolic function and increasing severity of tricuspid
regurgitation (Table 3). Patients with lower functional capacity had
lower subaortic RV-EF; RV-EF was 43+10% in patients with
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Table 1 Patient characteristics
Characteristic Overall n 5 149
Female gender, n 52 (35%)
Body surface area (m2) 1.8+0.2
Mean age at first follow-up (year) 19+2 (range 17–31)
Mean age at last follow-up (year) 28+7 (range 18–53)
Mean duration of follow-up at the adult
congenital clinic (year)
9+6 (range 0–28)
Mean time since atrial repair (year) 26+6 (range 13–41)
Documented baffle stenosis, n 16 (11%)
Surgical history
Simple transposition, n 107 (72%)
Previous balloon atrial septostomy, n 122 (82%)
Previous surgical atrial septectomy, n 72 (48%)
Median age at atrial repair (year) 1.2, IQR 1.0–2.1
Re-intervention for haemodynamic
residue, na
15 (10%)
Arrhythmia history
Atrial tachycardia, n 66 (44%)
Sustained ventricular tachycardia, n 7 (5%)
ICD-implantation, n 10 (7%)
Pacemaker implantation, n 35 (23%)
Functional class at last follow-up
NYHA class I, n 113 (76%)
NYHA class II, n 22 (15%)
NYHA class III, n 8 (5%)
NYHA class IV, n 5 (3%)
Medication at last follow-upb
ACE-inhibitors or angiotensin-receptor
blockers, n
45 (30%)
Beta-blockers (excluding Sotalol), n 27 (18%)
Diuretics, n 7 (5%)
Digoxin, n 8 (5%)
Amiodarone, n 8 (5%)
Sotalol, n 5 (5%)
Systemic ventricular function n ¼ 111
RV ejection fraction 50%, n 25 (23%)
RV ejection fraction 40–49%, n 36 (32%)
RV ejection fraction 30–39%, n 32 (29%)
RV ejection fraction ,30%, n 18 (16%)
ICD, implantable cardioverter-defibrillator; RV, right ventricular; NYHA,
New York Heart Association.
aRe-intervention included percutaneous intervention for baffle stenosis/leak (n ¼
7), re-do surgery for baffle stenosis/leak (n ¼ 6), surgical removal of an infected
pacemaker lead and subsequent baffle reconstruction (n ¼ 1), re-do surgery to
close a residual VSD (n ¼ 1).
bMedications are not mutually exclusive.
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NYHA class I (n ¼ 83), 41+ 13% in patients with NYHA class II
(n ¼ 20), and 23+ 7% in patients with NYHA class III or IV
(n ¼ 8; P,0.001 for NYHA class I vs. III/IV and for NYHA class
II vs. III/IV). There was an inverse linear correlation between
RV-EF and age [RV-EF (%) ¼ 5520.50  age in years: P ¼ 0.001;
Figure 1], QRS duration and age [QRS duration (ms) ¼
92þ0.74  age; P ¼ 0.02] at the time of assessment, and RV-EF
and QRS duration [QRS duration ¼ 157 ms21.1  RV-EF (%);
P,0.001; Figure 2].
Risk factors for sustained ventricular
tachycardia and/or sudden death
Sustained VT and/or SD occurred in 13 patients (9% of the cohort;
five patients with sustained VT, two patients with intractable VT,
six patients with SD). The Cox proportional hazard ratios for
the predictors of sustained VT/SD during follow-up in a univariate
analysis are shown in Table 4. Ventricular tachycardia/SD was more
likely to occur in patients with later repair (median age at the time
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Table 2 Deaths during follow-up
No. Complex
TGA
Age at death
(years)
RV functiona QRS duration
(ms)a
Clinical notes
1 Yes 37 RV-EF 19% 180 Sudden death, heart failure
2 Yes 25 RV-EF 39% 170 Sudden death
3 No 29 RV-EF 21% 180 Sudden death, heart failure, coronary anomaly, previous
myocardial infarction
4 No 18 Severe RV dysfunction
on echo
140 Previous stroke, heart failure
5 Yes 18 Severe RV dysfunction
on echo
220 Heart failure
6 No 24 RV-EF 42% 100 Status epilepticus
7 Yes 38 RV-EF 18% 140 Intractable VT after PA banding, heart failure, large baffle
leak
8 Yes 35 RV-EF 23% 170 Sudden death
9 Yes 29 RV-EF 15% 170 Perioperative death (heart transplantation), heart failure
10 No 21 Severe RV dysfunction
on echo
220 Intractable VT during ICD placement, heart failure
11 Yes 23 RV-EF 51% 120 Sudden death, heart failure, severe pulmonary
hypertension
12 Yes 24 RV-EF 47% — Cerebral abscess
13 No 19 Mild RV dysfunction on
echo
100 Sudden death, atrial fibrillation
ICD, implantable cardioverter-defibrillator; PA, pulmonary artery; VT, ventricular tachycardia; RV-EF, right ventricular ejection fraction.
aAssessment of RV function and QRS duration at last clinic visit prior death.
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Table 3 Characteristics of the cohort by age-related quartiles
Quartile 1
(age 18–23)
Quartile 2
(age >23–28)
Quartile 3
(age >28–32)
Quartile 4
(age >32–53)
P-value
Total, n 36 38 36 39
QRS duration, ms (n) 114+30 (36) 105+20 (38) 110+26 (35) 125+32 (33)† 0.03
Supraventricular tachycardia, n 8 (22%) 14 (37%) 18 (50%)* 26 (67%)*†
Degree of tricuspid regurgitationa 1.2+0.6 1.3+0.6 1.6+0.8 1.5+0.7 0.10
Grade of subaortic RV dysfunctiona 1.7+0.8 1.9+0.5 2.2+0.5† 2.1+0.6 0.01
RV-ejection fraction, % (n) 45+12 (17) 45+9 (29) 40+11 (32) 36+12 (33)†‡ 0.003
RV, right ventricular.
*P,0.05 compared with Quartile 1.
†P,0.05 compared with Quartile 2.
‡P,0.05 compared with Quartile 3.
aDegree of tricuspid regurgitation and grade of RV dysfunction assessed echocardiographically.
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of operation 3.0, IQR 1.5–4.0 years vs. 1.2, IQR 0.9–2.0 years for
patients without adverse event, P ¼ 0.003), with complex transpo-
sition or with NYHA class III. A history of atrial tachyarrhythmia
was not a statistically significant predictor of an event in this popu-
lation. Patients with more than moderate tricuspid regurgitation or
more than moderately depressed RV function (measured by echo-
cardiography) were more likely to have had a VT/SD. The mean
RV-EF was lower in patients with events compared with those
without (26+ 13 vs. 42+10%, P ¼ 0.007).
Figure 3 depicts the QRS duration in individual patients with and
without VT/SD. The maximal non-paced QRS duration was 165+
34 ms in the 13 patients with a serious arrhythmic event compared
with 107+21 ms in 128 event-free survivors (P,0.001). The
ROC analysis showed that a QRS duration 140 ms had the
best ability to differentiate between these two groups of patients
with a sensitivity of 85% and specificity of 90%. The area under
the ROC curve was 0.92 (95% CI 0.82–1.00). Eighteen percent
(25/141) of patients without permanent ventricular pacing had a
QRS duration 140 ms and 11 of these patients had an arrhythmic
event during follow-up. Only 2 of 116 patients with QRS duration
,140 ms had a serious arrhythmic event during follow-up
(negative predictive value 98%).
Discussion
In this study, we have explored the changing clinical profile of aging
patients with atrial switch procedures for complete TGA. We
found that sustained VT/SD occurred in 9% of our cohort during
a mean follow-up of 9 years after transition of care from the pae-
diatric to the adult clinic. Subaortic RV systolic dysfunction was
increasingly common in this aging population. Age, systemic ventri-
cular function, and duration of the QRS complex were interrelated
and all were associated with sustained VT/SD. Patients with a QRS
duration 140 ms had a .10-fold risk for SD or sustained VT
compared with those with QRS duration ,140 ms.
Sustained VT is rarely observed during childhood after a
Mustard or Senning operation. Gelatt et al.7 observed non-
sustained VT in only 14 of 482 children (3%) and there was no
episode of sustained VT during a median follow-up period of
11.5 years. In another retrospective study comparing 47 children
after an atrial switch procedure with SD events to 93 matched
controls (same operation and no SD event), there was only one
documentation of a VT prior to the event in the entire cohort.8
The mean age at the SD event was 12 years with an average post-
surgery interval of 11 years. Previously recorded Holter ECGs in
66 of 140 children did not show any VT. By comparison, in our
adult TGA population, 5% of patients had sustained VT.
The reported incidence of systemic ventricular dysfunction in
patients with atrial switch operations for TGA has varied from
10 to 61%.7,13– 15 The large variation in reported RV function
may partly be attributed differing ages between study populations
and differences in imaging modalities used to assess systemic ven-
tricular function. Relying on quantitative RV function measurement,
we observed a steady decline in RV-EF as our patients grew older.
This decline was more evident in patients over age 30 years. There
was a large variation in RV-EF for any given age, but RV-EF was
severely reduced in one-third and normal in ,10% of the oldest
quartile of our patients (i.e. patients .32 years). This observation
is in keeping with a study from the Netherlands, assessing RV
function by echocardiography 14 and 25 years after a Mustard pro-
cedure.15 Sixty-one percent of patients showed moderate-
to-severe RV dysfunction 25 years after surgery, although all
patients had good RV function 11 years earlier. Our findings
support the concern that RV systolic performance will be a
major factor for the aging TGA patient following an atrial switch
operation.
Previously identified risk factors for death in survivors (.30
days) of an atrial switch operation include cardiac morphology
(i.e. complex TGA),16,17 surgery in an earlier decade,7,15 operative
period arrhythmias,7 a history of supraventricular arrhythmias
during follow-up,8,18 and advanced NYHA functional class.8,18,19
These risk factors were derived predominantly from paediatric
cohorts. Similar to this study, SD was the predominant mode of
late death with an incidence of 0.5%/year. As reported in prior
Figure 1 Inverse correlation between subaortic RV-ejection
fraction (EF) and age at the time of quantitative assessment of sys-
temic ventricular function [RV-EF (%) ¼ 5520.50  age (years),
P ¼ 0.001].
Figure 2 Inverse correlation between RV-ejection fraction (EF)
and QRS duration (QRS duration ¼ 157 ms—1.1  RV-EF (%),
P,0.001).
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studies, we also frequently observed atrial tachyarrhythmias in
patients with sustained VT/SD, but this association did not reach
statistical significance. Our findings suggest that with increasing
age, atrial arrhythmias may be less predictive of SD than systemic
RV dysfunction and a broad QRS complex. In paediatric series, sig-
nificant RV systolic dysfunction and/or broad QRS complexes are
probably too uncommon to allow for recognition as markers of an
adverse outcomes. For instance, in the study of Kammeraad et al.,8
RV systolic function was severely impaired in five (26%) SD cases
and one (3%) control, whereas in our study all but one patient with
sustained VT had a systemic RV-EF ,30%. Similarly, QRS duration
was 99 and 94 ms in paediatric patients with and without SD,
whereas our adult patients with adverse arrhythmic events had a
QRS duration of 165 ms compared with 108 ms in adults
without event. In addition, adults with a TGA and atrial switch
operations can be considered a selected group of ‘paediatric
survivors’ and may therefore have a different clinical profile and
attrition rate compared with the original paediatric patient
cohort. Hence, predictors of an adverse outcome may vary not
just as a function of time between adult and paediatric TGA
patients but also due to a selection bias.
In patients with acquired heart disease and left heart dysfunc-
tion, prolongation of the QRS due to left-sided intraventricular
conduction delay is associated with lower functional NYHA
class, worse left ventricular function and higher mortality
rates.20,21 Prolongation of QRS and severely decreased left ventri-
cular function secondary to ischaemic and non-ischaemic events
have an additive effect on mortality.22 In our patients, QRS
duration 140 ms was associated with lower functional NYHA
class, worse subaortic RV function and higher mortality, and may
be an equally important prognostic marker as it is in left-sided
heart failure. Increasing QRS duration in adult TGA patients corre-
lates with the extent of late gadolinium enhancement on CMR,23
and with the decline in RV function and functional capacity over
time.15 It is unknown, if QRS duration in the setting of a failing sys-
temic RV is associated with mechanical RV dyssynchrony or if
there would be a favourable response to cardiac resynchronization
therapy in this population. Finally, the indications for ICD implan-
tation in adult patients with TGA and subaortic RV dysfunction
are not known. Other issues, such as the complexities and risks
associated with lead placement to achieve adequate defibrillation
thresholds need to be factored into decision making.24
Limitations
Because our centre is a regional referral centre, the population
may represent a more complex group of patients compared with
those followed at local or regional centres. Thus, the prevalence
of VT/SD could be overestimated. By exclusively studying late
outcome in adult TGA patients previously followed at our local
regional paediatric centre, we intended to minimize the referral
bias of complex adult patients referred to us from other centres.
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Table 4 Univariate Cox regression hazard ratios for serious arrhythmic advents
Sustained VT/SD Hazard ratio (95% CI) P-value
Yes (n 5 13) No (n5 136)
Medical history
Complex TGA (n ¼ 42), n 8 (62%) 34 (25%) 4.9 (1.5–16.0) 0.008
NYHA class III (n ¼ 13), n 8 (62%) 5 (4%) 9.8 (3.0–31.6) ,0.001
Atrial tachycardia (n ¼ 66), n 11 (85)% 55 (40%) 2.7 (0.6–13.0) 0.21
Cardiac imaging
Moderate tricuspid regurgitation (n ¼ 42), n 10 (77%) 32 (24%) 5.4 (1.5–20.0) 0.01
RV-ejection fraction decrease/10% 2.2 (1.2–4.0) 0.01
.Moderate RV dysfunction assessed echocardiographically (n ¼ 34), n 8 (62%) 26 (20%) 3.6 (1.1–11.2) 0.03
Electrocardiographic features
QRS duration 140 ms (n ¼ 25), n 11 (85%) 14 (10%) 13.6 (2.9–63.4) ,0.001
Per 10 ms increase in QRS duration 1.3 (1.1–1.5) ,0.001
TGA, transposition of the great arteries, NYHA, New York Heart Association, RV, right ventricular.
Figure 3 The QRS duration in patients with (n ¼ 13) and
without (n ¼ 128) serious arrhythmic event (sustained VT and/
or SD).
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Overall, the prevalence of patients with simple TGA1,2 or QRS
duration in our TGA patients were comparable to prior
studies.15,25 Alternatively, the prevalence of SD could be underes-
timated, if the lost to follow-up cohort of patients are simply non-
survivors (having suffered VT or SD). Difference in definition of SD
could also affect the prevalence estimates as well as the predictors
of outcome. Thus, systematic follow-up of this population may help
to detect earlier structural or electrophysiological problems,
initiate earlier decision making for interventions and perhaps
result in better outcomes.
One of the most consistent reported markers of VT/SD in pae-
diatric patients is atrial tachycardia.7,8 The small number of events
(VT/SD) remains a limitation of this study. We cannot exclude the
possibility that our study was underpowered to identify this associ-
ation in the adult population. The increasing prevalence of atrial
arrhythmias as patients age post-repair may reduce its predictive
value for the adverse events studied in our paper. Furthermore,
because only adult patients were included in this study, there
exists a potential selection bias. Children who had died were not
included in this cohort. Nonetheless, this bias is unlikely to signifi-
cantly change the impact of our findings that provide insight into
the clinical features associated with VT/SD in adult patients after
Mustard operations.
Our routine clinical surveillance does not always include Holter
monitoring and therefore we were unable to reliably assess the
prevalence of non-sustained VT. Because of missing data, we
were not able to analyse serial changes in RV-EF or QRS duration
in the same patient over several years. Further studies may be
necessary to determinate, if the rate of changes in RV function
and QRS duration over time is more predictive of an adverse
event.
Conclusions
Sustained VT/SD occurred in 9% of our adult cohort of patients
with TGA and a Mustard operation. Age, systemic ventricular func-
tion, and duration of the QRS complex were interrelated and these
factors were associated with sustained VT and/or SD. These vari-
ables can be used to help identify the high-risk patient.
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